Image de couverture de livre

Outcome of Premature Infants Treated With Chemotherapy for Neuroblastoma in France

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Dana Al Khalifa, Pascal Chastagner, Gudrun Schleiermacher, Julien Lejeune
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Pediatric Blood & Cancer
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Chemo‐Immunotherapy Rescue for High‐Risk Neuroblastoma Patients With Progressive Disease Before High‐Dose Chemotherapy: Real‐World Data From the SACHA‐France Study
par: Claudia Pasqualini, et autres
Publié: (2025)

Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and 123ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single‐Center Study
par: Anna Borovkov, et autres
Publié: (2025)

Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group
par: Hetal Dholaria, et autres
Publié: (2025)

Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post‐Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group
par: Rebecca J. Deyell, et autres
Publié: (2026)

Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project
par: Mallory R. Taylor, et autres
Publié: (2025)

Outcomes Based on Histological Tumor Necrosis and Predictive Clinical and Laboratory Parameters for Necrosis in Children With Osteosarcoma Treated on a Non‐High Dose Methotrexate‐Based Chemotherapy Backbone
par: Badira Cheriyalinkal Parambil, et autres
Publié: (2024)

Paraneoplastic Lupus Nephritis in a Child With Neuroblastoma Recurrence
par: Gabriele Mortari, et autres
Publié: (2026)

Chemotherapy–Surgery Interval Effects on Tumor Necrosis and Outcome in Children and Young Adults With Osteosarcoma
par: Rachel B. Mersfelder, et autres
Publié: (2024)

Evaluating the Genetic Overlap Between Congenital Heart Disease and Neuroblastoma Risk
par: Ji Yun Tark, et autres
Publié: (2025)

A 2035 Clinical Research Vision and Roadmap for High‐Risk Neuroblastoma
par: Lucas Moreno, et autres
Publié: (2025)

Routine Screening for Neuroblastoma in Harlequin Syndrome Without Otherwise Known Etiology
par: Colburn Yu, et autres
Publié: (2025)

Evaluation of TRPA1 as a Therapeutic Target in MYCN‐Amplified Neuroblastoma
par: Alexandra Seger, et autres
Publié: (2025)

Pancreas, Muscle, and Subcutaneous Fat Atrophy in Patients Undergoing Radiation for Neuroblastoma
par: Pradipta Debnath, et autres
Publié: (2026)

Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma
par: Aseel Bzour, et autres
Publié: (2025)

Rare EWSR1::PBX1 Fusion‐Positive Infant B‐ALL With Coexisting KRAS Mutation: Sustained Molecular Remission Achieved With Standard Chemotherapy
par: Xiaoyong Chen, et autres
Publié: (2025)

Incidence of Adrenal Insufficiency in Patients With High‐Risk Neuroblastoma: A Single‐Institution Analysis
par: Shachi Srivatsa, et autres
Publié: (2025)

Neuroblastoma Presenting With Bilateral Renal Artery Obstruction and Thrombotic Microangiopathy: A Case Report
par: Muhammed Bahaddin Ates, et autres
Publié: (2025)

A Rare Case of Infant B‐ALL With SIN3A::NUTM1 Fusion: Durable Molecular Remission Achieved With Standard Acute Lymphoblastic Leukemia Chemotherapy
par: Dong Peng, et autres
Publié: (2026)

A Rare Case of Concurrent Neuroblastoma and Acute Myeloid Leukemia With CBFA2T3::GLIS2 Fusion: A Diagnostic and Therapeutic Dilemma
par: Laura M. Molina, et autres
Publié: (2025)

Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti‐GD2 Monoclonal Antibody Therapy in Patients With Neuroblastoma
par: Wei Wei, et autres
Publié: (2025)

A Case of Pediatric Adrenocortical Carcinoma With McCune‐Albright Syndrome Masquerading as Spontaneously Regressing Neuroblastoma
par: Yu Lin, et autres
Publié: (2026)

Cognitive Outcomes in Children Treated for Ependymoma Diagnosed Under 36 Months: A Systematic Review
par: Sophie Thomas, et autres
Publié: (2025)

Cyclosporine Resolved Late Graft Failure After Autologous Transplantation for Neuroblastoma by Promoting CD4 T‐Cell Recovery
par: Yu Shiguta, et autres
Publié: (2026)

Aggressive Pediatric Primitive Round Cell Tumors with MN1::ZNF341 Fusion: A Mimic of Neuroblastoma
par: Serena Y. Tan, et autres
Publié: (2024)

Safety and Efficacy of Romiplostim in Maintaining Chemotherapy Interval and Dose Intensity in Pediatric Patients With Solid Tumors and Chemotherapy‐Induced Thrombocytopenia
par: Erica Tonti, et autres
Publié: (2026)

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131 I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era
par: Benjamin J. Lerman, et autres
Publié: (2026)

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience
par: Thomas J. Jackson, et autres
Publié: (2026)

Long‐Term Outcomes and Quality of Life of Children With Intracranial Ependymoma Treated With Pencil Beam Scanning Proton Therapy
par: Eymeric Le Reun, et autres
Publié: (2025)

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse
par: Vicente Santa‐Maria Lopez, et autres
Publié: (2026)

The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor
par: Nils Welter, et autres
Publié: (2026)

Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High‐Risk Neuroblastoma: A Large Single‐Center Experience
par: Elio Castagnola, et autres
Publié: (2026)

Life‐Threatening Infantile Fibrosarcoma in an Infant
par: Katharina Daugs, et autres
Publié: (2025)

Dabrafenib as a Therapeutic Option for Chemotherapy‐Refractory Pediatric Juvenile Xanthogranuloma
par: Mengxuan Wang, et autres
Publié: (2025)

Long‐Term Clinical Outcome and Quality of Life of Children, Adolescents, and Young Adults With Chordoma or Chondrosarcoma Treated With Pencil Beam Scanning Proton Therapy
par: Miriam Vazquez, et autres
Publié: (2025)

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus
par: Negar Shavandi, et autres
Publié: (2026)

Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
par: Ashley C. Holland, et autres
Publié: (2025)

A Little Known but Very Common Phenotype in Patients With Severe Congenital Neutropenia Due to HAX1 Deficiency: Premature Ovarian Insufficiency
par: Deniz Özalp Kızılay, et autres
Publié: (2025)

A nationwide phase II study of delayed local treatment for children with high‐risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN‐H‐11
par: Akihiro Yoneda, et autres
Publié: (2024)

Primary Hepatic Choriocarcinoma With Pulmonary Metastasis in an Infant: Diagnosis and Treatment
par: Jie Zhao, et autres
Publié: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
par: Mikhail Lemeshev, et autres
Publié: (2026)